Apimeds Pharmaceuticals US, Inc. (APUS) — Operating Income

Annual figures by fiscal year, from SEC filings.

2023: -$747.4K2024: -$1.28M2025: -$11.91M-$11.91M
2023Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$11.91M-834.2%
2024-$1.28M-70.6%
2023-$747.4K